Creative Planning’s Molecular Templates, Inc. MTEM Stock Holding History

Creative Planning’s Portfolio MTEM Stock Details MTEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-52	Closed	-$3K	–	3935
2017 Q2	$3K	Sell	52 -1	-2%	-$79	﹤0.01%	4222
2017 Q1	$5K	Buy	53 +43	+430%	+$4.02K	﹤0.01%	3991
2016 Q4	$1K	Hold	10	–	–	﹤0.01%	4525
2016 Q3	$1K	Hold	10	–	–	﹤0.01%	4472
2016 Q2	$1K	Hold	10	–	–	﹤0.01%	4247
2016 Q1	$1K	Buy	10 +5	+100%	+$295	﹤0.01%	4200
2015 Q4	$0	Sell	5 -91	-95%	-$44.9K	﹤0.01%	4636
2015 Q3	$65K	Hold	96	–	–	﹤0.01%	1862
2015 Q2	$64K	Hold	96	–	–	﹤0.01%	1017
2015 Q1	$65K	Buy	96 +90	+1,500%	+$59.3K	﹤0.01%	1836
2014 Q4	$3K	Buy	+6	New	+$3K	﹤0.01%	3739
2014 Q3	–	Hold	0	–	–	–	4200
2014 Q2	–	Hold	0	–	–	–	4008
2014 Q1	–	Sell	-43	Closed	-$34.9K	–	3797
2013 Q4	$33K	Sell	43 -13	-23%	-$9.8K	﹤0.01%	1890
2013 Q3	$43K	Hold	56	–	–	﹤0.01%	1610
2013 Q2	$49K	Buy	+56	New	+$47.4K	﹤0.01%	1395

Other funds holding MTEM

Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IBT

International Biotechnology Trust London, United Kingdom $297M AUM 17.25% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Creative Planning's MTEM Position: Q3 2017 in Review

Creative Planning sold out of Molecular Templates, Inc. (MTEM) in Q3 2017, closing a stake of 52 shares — an estimated $3K sold.

Creative Planning first reported a position in MTEM in Q2 2013 and held it in 14 quarters. The position peaked at $65K in Q3 2015. 29 funds tracked by Wall St. Rank hold MTEM as of Q3 2017.

Creative Planning reported no remaining Molecular Templates, Inc. position as of Q3 2017 after selling out during the quarter.
Creative Planning sold 52 Molecular Templates, Inc. shares in Q3 2017, an estimated $3K.
Creative Planning first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 14 quarters.
Creative Planning's Molecular Templates, Inc. position peaked at $65K in Q3 2015.
29 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q3 2017.

Based on Creative Planning's 13F filing for Q3 2017, filed 17 Oct 2017.